These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11231724)

  • 1. Headache, hypertension, and irbesartan therapy.
    Benseñor IM; Lotufo PA
    Arch Intern Med; 2001 Mar; 161(5):775-6. PubMed ID: 11231724
    [No Abstract]   [Full Text] [Related]  

  • 2. Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy.
    Hansson L; Smith DH; Reeves R; Lapuerta P
    Arch Intern Med; 2000 Jun; 160(11):1654-8. PubMed ID: 10847258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.
    Liberopoulos E; Christides D; Elisaf M
    J Hypertens; 2002 Feb; 20(2):347. PubMed ID: 11821722
    [No Abstract]   [Full Text] [Related]  

  • 4. Irbesartan slows the development of diabetic nephropathy by up to 70% in hypertensive diabetic patients.
    Cardiovasc J S Afr; 2001; 12(4):242-3. PubMed ID: 11766619
    [No Abstract]   [Full Text] [Related]  

  • 5. [Health economic aspects of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension].
    Schute LL
    Dtsch Med Wochenschr; 2004 Jun; 129(25-26):1448; author reply 1448. PubMed ID: 15213879
    [No Abstract]   [Full Text] [Related]  

  • 6. [Irbesartan--current trends in the management of hypertension].
    Dtsch Med Wochenschr; 1998 Feb; 123(8 Suppl):1-4. PubMed ID: 9531920
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enalapril and irbesartan in treatment of patients with arterial hypertension].
    Tashchuk VK; Ilashchuk TO
    Lik Sprava; 2002; (3-4):114-6. PubMed ID: 12145874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Observational study of blood pressure control and microalbuminuria in type 2 diabetics on Irbesartan or Irbesartan/HCTZ].
    Schmieder RE; Krekler M
    MMW Fortschr Med; 2005 Aug; 147(31-32):43. PubMed ID: 16128197
    [No Abstract]   [Full Text] [Related]  

  • 9. Irbesartan achieves consistent and effective use over 1 year.
    Cardiovasc J S Afr; 2001; 12(2):126. PubMed ID: 11474701
    [No Abstract]   [Full Text] [Related]  

  • 10. Irbesartan treatment in hypertension.
    Brown MJ
    Hosp Med; 1998 Oct; 59(10):808-11. PubMed ID: 9850301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irbesartan for hypertension.
    Med Lett Drugs Ther; 1998 Jan; 40(1019):18-9. PubMed ID: 9465857
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators.
    Larochelle P; Flack JM; Marbury TC; Sareli P; Krieger EM; Reeves RA
    Am J Cardiol; 1997 Dec; 80(12):1613-5. PubMed ID: 9416950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irbesartan prevents the progression of kidney disease or death in patients with type 2 diabetes and high blood pressure.
    Cardiovasc J S Afr; 2001; 12(4):240-1. PubMed ID: 11766617
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical overview of irbesartan: a new angiotensin II receptor antagonist.
    Pouleur HG
    Am J Hypertens; 1997 Dec; 10(12 Pt 2):318S-324S. PubMed ID: 9438776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of irbesartan and olmesartan in patients with hypertension (EARTH study).
    Morii J; Miura S; Shiga Y; Sugihara M; Arimura T; Sako H; Zhang B; Uehara Y; Saku K
    Clin Exp Hypertens; 2012; 34(5):342-9. PubMed ID: 22568596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases.
    Franscini LM; Von Vigier RO; Pfister R; Casaulta-Aebischer C; Fossali E; Bianchetti MG
    Am J Hypertens; 2002 Dec; 15(12):1057-63. PubMed ID: 12460701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT1-receptor antagonism in hypertension: what has been learned with irbesartan?
    Waeber B; Burnier M
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):23-33. PubMed ID: 15030294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan.
    Bunt T
    Clin Ther; 1999 Mar; 21(3):611-2. PubMed ID: 10321426
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
    Neutel JM
    Postgrad Med; 2011 Jul; 123(4):126-34. PubMed ID: 21680997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microalbuminuria in patients with hypertension and cardiovascular comorbidity, REAL observational study of treatment with Irbesartan/HCTZ].
    Tschöpe C; Tschöpe R; Unger T
    MMW Fortschr Med; 2006 Jun; 148(25):48. PubMed ID: 16859162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.